Abstract
A unique dermatopathology incident arose after administration of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine. Specifically, a transient purpuric interface dermatitis occurred 5 days post-second vaccine with the presentation of erythematous papules with erythema multiforme-type findings. A patient developed purpuric interface dermatitis with micro-vesiculation post-vaccination which ultimately resolved without sequelae.
| Original language | English |
|---|---|
| Journal | Dermatology Online Journal |
| Volume | 30 |
| Issue number | 3 |
| DOIs | |
| State | Published - May 2024 |
| Externally published | Yes |
Keywords
- COVID-19
- interface dermatitis
- microvesiculation
- purpuric
- vaccine reaction